Rare diseases
Investigational molecules
Locations
Back to Greece1 004 clinical trials in Piraeus, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy
GreeceStudy Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer
GreeceStudy Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
GreeceStudy of Acalabrutinib for Patients with Waldenström Macroglobulinemia
GreeceStudy on the Effectiveness and Safety of Lazertinib and Gefitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
GreeceStudy on the Effectiveness and Safety of Fenebrutinib and Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
GreeceStudy of Belantamab Mafodotin for Patients with Relapsed or Refractory AL Amyloidosis
GreeceStudy on the Effectiveness and Safety of Rozanolixizumab for Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOG-AD)
GreeceStudy on Durvalumab, Paclitaxel, Carboplatin, and Olaparib for Patients with Advanced or Recurrent Endometrial Cancer
GreeceStudy on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Resistant Bacterial Infections
GreeceStudy on Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
GreeceStudy on JDQ443 for First-Line Treatment in Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer
GreeceThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, particularly in non-small cell lung cancer and novel therapeutic combinations. Studies include investigations of targeted therapies and immunotherapy approaches.
Innovative research combining standard treatments with new therapeutic agents to improve patient outcomes.
Research initiatives targeting heart failure prevention and stroke prevention in patients with atrial fibrillation. Studies evaluate new therapeutic approaches for managing cardiovascular risks.
Trials focusing on both preventive measures and treatment of established cardiovascular conditions.
Clinical investigations in multiple myeloma and related blood disorders, exploring combination therapies and novel treatment approaches for patients with various blood-related conditions.
Studies examining innovative therapeutic combinations for improved patient outcomes.
Research focusing on treating Crohn's Disease and other inflammatory conditions, evaluating new therapeutic options and combination treatments for better disease management.
Studies aimed at improving treatment outcomes in chronic inflammatory diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
